MIT HEALS and Deshpande Center Momentum Grants

The Momentum Grants are a joint initiative of the MIT Health and Life Sciences Collaborative (MIT HEALS) and the MIT Deshpande Center for Technological Innovation. These competitive grants support bold, translational research with a clear path to impact.

HEALS + Deshpande Momentum Grants

  • Break disciplinary silos
  • Ask new and ambitious scientific questions
  • Address bottlenecks in research or care
  • Leverage cutting-edge technologies
  • Offer transformative potential for human health

Each Momentum Grant provides:

  • Up to $125,000 in funding over one year
  • Dedicated mentorship from Deshpande Center Catalysts to help teams advance commercialization and implementation milestones

Aug 18, 2025

Applications open

Oct 15, 2025

Application Deadline

Dec, 2025

Award Notification

Jan 1, 2026

Project Start Date

Will our team be able to spend on our funded grant beyond the end of the grant period (December 31, 2026)?

We encourage teams to budget for work that can be accomplished within the grant year, but will allow carry forward with approval on a case-by-case basis.

Are there any unallowable expenses on Momentum grants?

No funding can be sent to outside collaborators. Funds should be spent in accordance with MIT policies related to sponsored research.

Can I use Momentum Grant funding for equipment or travel?

Yes, Momentum Grant funding can be used for equipment and travel in support of the funded research.

Can I submit more than one proposal?

Yes.

Can I apply for a HEALS Momentum Grant and a Climate Project Momentum Grant in the same cycle?

Yes.

Can you provide examples of projects that are or are not consistent with this opportunity?

Yes. This proposal is about assessing translational potential of an existing asset or technology. It is not suitable for exploring wholly new ideas.


Example 1: A lab may have developed extensive biological data to nominate or credential a potential target for drug intervention. A successful application can involve specific experiments designed to explore the efficacy or toxicity associated with a new drug candidate in disease-relevant model systems, to gather critical pharmacologic data, or to explore formulation or drug delivery strategy. An unsuccessful proposal would involve initiating a new drug discovery approach for the target from scratch.


Example 2: A lab may have identified a biomarker for a disease. A successful application might involve integration of the biomarker with an existing measurement technology to provide insights into patient health, involving in vitro or in vivo proof-of-concept experiments. An unsuccessful proposal would involve the initial biomarker discovery. Another unsuccessful proposal would involve developing a new measurement technology from scratch.


Example 3: A lab may have developed a software package or AI tool for a health-related application (e.g., analyzing patient data, drug discovery, image analysis, etc.). A successful proposal may involve deploying or benchmarking the tool with relevant existing data sets or problems. An unsuccessful proposal would involve generating the field data to inform a model. Another unsuccessful proposal would involve developing the underlying AI tool.

Visit the InfoReady site for full application details and templates. For questions about proposal fit or focus, please contact Andi Blumenau at the Deshpande Center.